Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Fahn

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
NPJ Parkinson'S Disease|April 13, 2018
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's diseaseDavid Sulzer, Clifford Cassidy, Guillermo Horga, et al.
Clinical Neuropharmacology|June 4, 2008
A study of chorea after tetrabenazine withdrawal in patients with Huntington diseaseSamuel Frank, William Ondo, Stanley Fahn, et al.
Archives of Neurology|September 17, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Neurorehabilitation and Neural Repair|December 18, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.
Journal of Molecular Neuroscience : MN|December 24, 2011
Clinical and pathological characteristics of LRRK2 G2019S patients with PDMarkos Poulopoulos, Etty Cortes, Jean-Paul G Vonsattel, et al.
Molecular Neurobiology|April 29, 2025
Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersEmma N Somerville, Lynne Krohn, Konstantin Senkevich, et al.
Research Square|June 17, 2024
Genome-wide association study of glucocerebrosidase activity modifiersEmma N Somerville, Lynne Krohn, Konstanin Senkevich, et al.
Archives of General Psychiatry|April 7, 2004
Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trialCynthia McRae, Eva Cherin, T Gayle Yamazaki, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
NPJ Parkinson'S Disease|April 13, 2018
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's diseaseDavid Sulzer, Clifford Cassidy, Guillermo Horga, et al.
Clinical Neuropharmacology|June 4, 2008
A study of chorea after tetrabenazine withdrawal in patients with Huntington diseaseSamuel Frank, William Ondo, Stanley Fahn, et al.
Archives of Neurology|September 17, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Neurorehabilitation and Neural Repair|December 18, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.
Journal of Molecular Neuroscience : MN|December 24, 2011
Clinical and pathological characteristics of LRRK2 G2019S patients with PDMarkos Poulopoulos, Etty Cortes, Jean-Paul G Vonsattel, et al.
Molecular Neurobiology|April 29, 2025
Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersEmma N Somerville, Lynne Krohn, Konstantin Senkevich, et al.
Research Square|June 17, 2024
Genome-wide association study of glucocerebrosidase activity modifiersEmma N Somerville, Lynne Krohn, Konstanin Senkevich, et al.
Archives of General Psychiatry|April 7, 2004
Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trialCynthia McRae, Eva Cherin, T Gayle Yamazaki, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
Pageof 17